Share
Eli Lilly and Company and Livongo Health today announced a strategic collaboration to study real-world evidence and develop new insights to reduce the burden on people living with diabetes. The research collaboration will combine real-world behavioral studies and claims data to advance knowledge about effective interventions in diabetes care. The companies aim to contribute to...
Share
Researchers in Japan have for the first time clarified the thyroid cancer detection rate in children and adolescents following the Fukushima Nuclear Power Plant disaster in March 2011, according to a study recently published in The Journal of Clinical Endocrinology & Metabolism. The team, led by Hiroki Shimura, MD, PhD, of Fukushima Medical University, points...
Share
Lipid nanodiscs stabilize misfolding protein intermediates red-handed When proteins misfold, accumulate, and clump in insulin-producing cells in the pancreas, they can kill these cells. Now, researchers at the Technical University of Munich (TUM), the University of Michigan, and the Helmholtz-Zentrum Muenchen have obtained a structural snapshot of these proteins when they are most toxic, detailing...
Share
Researchers in Norway have found very little incidence of end-stage renal disease (ESRD) among those with childhood-onset type 1 diabetes who were followed for up to 42 years, according to a study recently published in Diabetes Care. Researchers led by Torild Skrivarhaug, PhD, of Oslo University Hospital, evaluated patient data for a follow-up period of...
Share
Study suggests even mild thyroid dysfunction may contribute to unexplained infertility New research suggests that a slightly underactive thyroid may affect a woman’s ability to become pregnant—even when the gland is functioning at the low end of the normal range, according to a study published in The Journal of Clinical Endocrinology & Metabolism. The study...
Share
Researchers in South Africa have shown that regularly drinking sugar-sweetened beverages (SSBs) contributes to the development of diabetes, high blood pressure, metabolic syndrome, and other endemic health problems, according to a review recently published in the Journal of the Endocrine Society. The review’s authors, led by M. Faadiel Essop, PhD, of Stellenbosch University in Stellenbosch,...
Share
The U.S. Food and Drug Administration (FDA) approved semaglutidea once-weekly glucagon-like peptide (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. The drug, produced by Novo Nordisk and marketed as OZEMPIC®, is administered once weekly, on the same day each week, and can be taken...
Share
Researchers have described clinical features and outcomes in children with adrenocortical tumors (ACTs) without germline TP53 mutations, according to a study recently published in the Journal of Clinical Oncology. Emilia Modolo Pinto, PhD, Raul C. Ribeiro, MD, and colleagues of St. Jude Children’s Research Hospital in Memphis, Tenn., point out that ACTs are cancers caused...
As much as we know today about the endocrine system and the effects it has on the body, there remains so much that we do not know. Discoveries are made every day, and our understanding of the endocrine system is always growing and changing. Serving patients to the best of an endocrinologist’s abilities means being aware of all the latest developments in endocrine research. This includes the newest and most complete information concerning such endocrinology research topics as new treatments and new methods for disease prevention. Identifying symptoms and making the connections between those symptoms and endocrine disease can lead to greater understanding and ultimately better treatment for patients. More advanced prevention techniques can help patients stave off disease before it can impact their lives. Having the most current information can make a tremendous difference in the quality of life for your patients.
This section features some of the most current and forward-looking articles concerning the latest research in endocrinology. Written by and for endocrinologists, these articles are provided to keep you up to date with the most relevant developments in the field of endocrinology. You can access the information you need about new technology, new treatments and general information to help you serve your patients with better overall care. Our understanding of the endocrine system is always evolving. With Endocrine News, you can ensure that your knowledge of the field won’t be left behind. What’s more, your patients will always have access to the most advanced information out there.
